North American region is expected to hold the largest market share in the global oncology companion diagnostics market

August 09 19:02 2022
North American region is expected to hold the largest market share in the global oncology companion diagnostics market
Oncology Companion Diagnostics Market | DataM Intelligence
Oncology Companion Diagnostics Market is Segmented By Product (Instrument, Consumables, Software), By Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), Other), By End User (Hospital, Diagnostic Laboratory, Other), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Oncology Companion Diagnostics Market Overview:

Oncology companion diagnostics market size was valued at USD million in 2021 and is estimated to reach USD million by 2029, growing at a CAGR of 12% during the forecast period (2022-2029). Oncology has several financial advantages. The ability of companion diagnostics (CDx) assays to shorten clinical trial timelines has increased pharmaceutical companies’ adoption rate of these assays. Companion diagnostics can improve the treatment outcomes of various diseases by providing clinicians with clear clinical grounds for diagnosis and treatment and proper management of patient resources and national insurance policies by reducing the use of costly targeted chemotherapy drugs that aren’t needed.

Several recent regulatory guidance documents have focused on companion diagnostics, and the drug–diagnostic co-development process has become increasingly relevant and necessary. Despite this, the promise of companion diagnostics has yet to be fully realized, and a number of issues remain to be resolved.

Early detection of COVID-19 is becoming increasingly important in the market, as it can aid in the identification of the best treatment for patients infected with the virus. The polymerase chain reaction (PCR) test, which uses nasopharyngeal swabs or other upper respiratory tract specimens, including throat swabs, is the most used and reliable test for COVID-19 diagnosis.

The growing prevalence of cancer, increasing R&D, and reimbursement policies are all factors expected to drive the market growth in this region. For instance, the rising cancer burden in the United States is expected to fuel market growth.

Oncology Companion Diagnostics Market is Segmented By Product (Instrument, Consumables, Software), By Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), Other), By End User (Hospital, Diagnostic Laboratory, Other), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Some of the key players in the market are Agilent Technologies, Inc., Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., ARUP Laboratories, Abbott, Myriad Genetics, Inc., bioMérieux SA, Invivoscribe, Inc., Pillar Biosciences, Inc.

Download Sample Brochure @ https://www.datamintelligence.com/download-sample/oncology-companion-diagnostics-market

Table of Content:

  1. Methodology and Scope
    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Market Definition and Overview
  3. Executive Summary
    1. Market Snippet By Product
    2. Market Snippet By Technology
    3. Market Snippet By End User
    4. Market Snippet By Region
  1. Oncology Companion Diagnostics Market-Market Dynamics
    1. Market Impacting Factors
      1. Drivers:
        1. The increasing demand for companion diagnostics for cancer
      2. Restraints:
        1. The problems associated with companion diagnostics
      1. Opportunity
      2. Impact Analysis
  1. Industry Analysis
    1. Porter’s Five Forces Analysis
    2. Supply Chain Analysis
    3. Pricing Analysis
    4. Regulatory Analysis
    5. Unmet Needs
  1. COVID-19 Analysis
    1. Analysis of Covid-19 on the Market
      1. Before COVID-19 Market Scenario
      2. Present COVID-19 Market Scenario
      3. After COVID-19 or Future Scenario
    1. Pricing Dynamics Amid Covid-19
    2. Demand-Supply Spectrum
    3. Government Initiatives Related to the Market During Pandemic
    4. Manufacturers Strategic Initiatives
    5. Conclusion 
  1. By Product
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    3. Market Attractiveness Index, By Product
      1. Instrument
      2. Introduction
        1. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
      1. Consumables
      2. Software
  1. By Technology  
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology 
    3. Market Attractiveness Index, By Technology 
      1. Immunohistochemistry (IHC)*
        1.  
          1. Introduction
          2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
      1. Polymerase Chain Reaction (PCR)
      2. Next-Generation Sequencing (NGS)
      3. In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
      4. Other
  1. By End User
    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      2. Market Attractiveness Index, By End User
    1. Hospital*
      1. Introduction
      2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    1. Diagnostic Laboratory
    2.  Other
  1. By Region
    1. Introduction
      1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
      2. Market Attractiveness Index, By Region
    1. North America
      1. Introduction
      2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    1. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    1. South America
      1. Introduction
      2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    1. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    1. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  1. Competitive Landscape
    1.  Key Developments and Strategies
    2. Company Share Analysis
    3. Product Benchmarking
  1. Company Profiles
    1. F. Hoffmann-La Roche Ltd.  *
      1. Company Overview
      2.  Product Portfolio and Description
      3.  Key Highlights
      4.  Financial Overview
    1. Agilent Technologies, Inc.
    2. Illumina, Inc.
    3. Qiagen N.V
    4. Thermo Fisher Scientific, Inc.
    5. ARUP Laboratories
    6. Myriad Genetics, Inc.
    7. Biomérieux Sa
    8. Invivoscribe, Inc.
    9. Pillar Biosciences, Inc.(*LIST NOT EXHAUSTIVE)

 

Related Reports:

Companion Diagnostics Market is segmented By Indications (Oncology (Colorectal Cancer, Leukemia, Breast Cancer, Lung Cancer, Others), Neurology, Others), By Technology (In-situ Hybridization, Immunohistochemistry, Polymerase Chain Reaction, Next-Generation Sequencing, Others), By End-User ( Pharmaceutical and Biopharmaceutical Companies, Research Laboratories, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share Outlook, and Opportunity Analysis, 2022-2029

Companion Animal Health Market is segmented By-Products (Vaccines, Anti-Infectives, Medicinal Feed Additives, Parasiticides, Diagnostics, Others), By Animals (Cats, Dogs, Equine, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2022-2029

Wild Animal Tracking Market is segmented By Product Type (Backpacks, Collars, Implants, Others), By Technology (Argos Systems, GPS Systems, VHF Transmitting Systems, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029

Additional Benefits Post Purchase:

1) Unlimited Analyst support for a period of 1 year.

2) Any query with regards to the scope offered will be addressed within 24- 48 hours.

3) An excel sheet with market numbers will be provided separately.

The Full Report has the below insights:

  • The report offers a comprehensive evaluation of the market in terms of Market Value (US$) and Y-o-Y Growth Rates (%). It does so via in-depth qualitative insights, historical data (2020-2021), and verifiable projections about market size during the forecast period (2022-2029).
  • Visualize the composition of the global market segmentation by Product, Technology, Application, End user, and regions highlighting the key commercial assets and players.
  • Identify commercial opportunities in the market by analyzing trends and co-development deals.
  • The report also covers data insights on various industry forces such as porter’s five forces, regulations in each country, reimbursement scenario, technological advancements, PEST analysis, and pricing analysis.
  • Excel data sheet with thousands of data points of cardiac pacemaker market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study. 
  • Product mapping in excel for the key product of all major market players
  • The report will provide access to approximately 50+ market data tables, 40+ figures, and close to 180 pages. 

About Us:

DataM Intelligence 4Market Research is a market intelligence platform that gives access to syndicated, customized reports and consulting to its clients in one place. As a firm with rich experience in research and consulting across multiple domains, we are a one-stop solution that will cater to the needs of clients in key business areas. DataM Intelligence has an online platform whose coverage includes industries such as chemicals and materials, agriculture, health care services, animal feed, and food & beverages among others. Our platform has Insights on markets that uncover the latest market research data that are distinct from the competition. With coverage across 10 major industries in the marketplace research, DataM Intelligence benefits thousands of companies by helping them take their innovations early to the market by providing a complete view of the market with statistical forecasts. Our strategy-centric framework and value-added services will let individuals and corporates ease of access and custom personalization to research and markets.

Media Contact
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/research-report/oncology-companion-diagnostics-market